Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yali Liu
Institution:
Daiichi Sankyo (United States)
Observed institution:
Daiichi Sankyo (United States)
ORCID:
0000-0003-2125-3755
Observed ORCID:
0000-0003-2125-3755
OpenAlex ID:
A5022448589
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
2022
·
Guy Jerusalem
, Yeon Hee Park
, et al.
·
Cancer Discovery
·
118
PDF
Data from Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
2023
·
Guy Jerusalem
, Yeon Hee Park
, et al.
Supplementary Data from Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
2023
·
Guy Jerusalem
, Yeon Hee Park
, et al.
Supplementary Data from Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
2023
·
Guy Jerusalem
, Yeon Hee Park
, et al.
PDF
Supplementary Data from Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
2023
·
Guy Jerusalem
, Yeon Hee Park
, et al.
PDF
Show more works
View as search
Works count:
5
Citation count:
118
H-index:
1
I10-index:
1
Year
Topic
Type